BioCryst’s Oral Therapy For HAE Attacks On Track With Exploratory Phase II Success

 
• By Joseph Haas
  
Medic staff at work in the laboratory. Background
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D